 WEST LAFAYETTE, Ind., April 13, 2021 GLOBE NEWSWIRE -- Inotiv, Inc. NASDAQ:NOTV the Company, We, Our or Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that the Company has entered into an agreement to purchase substantially all of the assets of HistoTox Labs, Inc. HistoTox Labs, a full-service histopathology contract research organization CRO offering medically relevant non-clinical and clinical services to the pharmaceutical, biotech, and academic communities. 